We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Drug Targets Early Instigator of Alzheimer's Disease

News   Aug 15, 2019 | Original story from Arizona State University

 
Drug Targets Early Instigator of Alzheimer's Disease

DYR219 is a powerful new drug developed by Travis Dunckley and his colleagues and described in the new study. Its strength lies in the fact that it can target both of the leading pathologies associated with Alzheimer's disease--plaques, (caused by the protein amyloid beta) and tangles, (caused by the tau protein). Credit: Graphic by Shireen Dooling

 
 
Advertisement
 

RELATED ARTICLES

Researchers Cultivate Mini Lungs for SARS-CoV-2 Research

News

A Bochum-based team intends to use organoids derived from stem cells to study the progression of SARS-CoV-2 infection and to identify antiviral substances.

READ MORE

FDA Grants Fast Track Designation to Onvansertib for Second-line Treatment of KRAS-mutated Colorectal Cancer

News

The U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to onvansertib, an oral and highly-selective Polo-like Kinase 1 (PLK1) inhibitor, for the second-line treatment of patients with KRAS-mutated metastatic colorectal cancer.

READ MORE

Solving the Medical Mystery of Anesthesia

News

Researchers have solved the longstanding mystery of the mechanisms behind the effects of anesthetics.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE